Evidence map›Paper›PMID 30781728›Full record

ArticlePharmaceutics2019

Mono- and Bi-Phasic Cellulose Acetate Micro-Vectors for Anti-Inflammatory Drug Delivery.

Vincenzo Guarino, Rosaria Altobelli, Tania Caputo, Luigi Ambrosio, Sergio Caserta, Paola Calcagnile, Christian Demitri

Abstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vincenzo GuarinoInstitute for Polymers, Composites and Biomaterials, National Research Council of Italy, Naples 80125, Italy. vguarino@unina.it.ORCID 0000-0003-1546-3721
Rosaria AltobelliInstitute for Polymers, Composites and Biomaterials, National Research Council of Italy, Naples 80125, Italy. rosaria.altobelli@gmail.com.
Tania CaputoInstitute for Polymers, Composites and Biomaterials, National Research Council of Italy, Naples 80125, Italy. taniacaputo87@gmail.com.
Luigi AmbrosioInstitute for Polymers, Composites and Biomaterials, National Research Council of Italy, Naples 80125, Italy. ambrosio@unina.it.
Sergio CasertaDepartment of Chemical, Materials and Production Engineering, University of Naples Federico II, Naples 80125, Italy. sergio.caserta@unina.it.ORCID 0000-0002-4400-0059
Paola CalcagnileIMAST SCaRL, Naples 80133, Italy. calcagnile_paola@hotmail.it.
Christian DemitriDepartment of Engineering for Innovation, University of Salento, Lecce 73100, Italy. christian.demitri@unisalento.it.ORCID 0000-0002-1145-6674

Funding

MIUR Italy PON02 3203241
6 · The paper itself

Abstract

In recent years, different processing technologies have been engineered to fabricate capsules or particles with peculiar properties (e.g., swelling, pH-sensitive response) at the micro and sub-micrometric size scale, to be used as carriers for controlled drug and molecular release. Herein, the development of cellulose acetate (CA) micro-carriers with mono- (MC) or bi-phasic (BC) composition is proposed, fabricated via electrohydrodynamic atomization (EHDA)-an electro-dropping technology able to micro-size polymer solution by the application of high voltage electrostatic forces. Image analysis allows identification of the process parameters to optimize morphology, in terms of size distribution and shape. Meanwhile, an accurate rheological study has enabled investigating the interface between CA solutions with different viscosities to optimize BC systems. Release tests have confirmed that BC carriers can retain the drug more efficiently in acidic conditions, also providing a more gradual and sustained release until six days, with respect to MC carriers. Hence, all these results have proven that biphasic architecture significantly improves the capability of CA microcarriers to release ketoprofen lysinate, thus suggesting a new route to design core/shell systems for the retarded oral administration of anti-inflammatory drugs.

Indexed as

core/shell structuredrug releaseelectrohydrodynamic atomizationmicro-carriersoral delivery

Identifiers

PMID30781728
PMCPMC6409530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.